Chad's health ministry. It runs the national cancer control programme, publishes the national list of essential medicines, grants marketing authorisations for medicines, and laid the first stone of a national cancer centre in N'Djamena in June 2025, with Kuwaiti financing and IAEA technical support.
The Ministry of Public Health has carried several names; its 2022 essential medicines list was issued as the Ministry of Public Health and National Solidarity, and in 2025 it was the Ministry of Public Health and Prevention. Its multisectoral plan against non-communicable diseases for 2017 to 2021 said that cancer cases were referred to national hospitals and a few private clinics in N'Djamena, that medicines for these diseases were costly and often out of stock, and that they were almost absent from the free emergency care list in place since 2007. Under the heading of cancer, the plan set out to establish a cancer registry, build and open a national cancer treatment centre, equip five hospitals with pathology laboratories, set up screen-and-treat units for cervical cancer in six health facilities, and build cancer departments in Abéché and Sarh. The coordinates on this record are an approximate N'Djamena city point.
In January 2022 the coordinator of the national cancer control programme told an IAEA meeting that an IAEA-funded feasibility study for a radiotherapy and nuclear medicine centre had been carried out in 2008, and the minister said the centre was financed by the Kuwait Fund and that staff would need three to four years of training. On 15 June 2025 the first stone of the Centre National d'Excellence en Cancérologie, planned with 50 beds, was laid at Karkadjerie in N'Djamena. In September 2024 the minister opened a pathology department at CHU La Renaissance.
The Ministry's General Directorate of Pharmacy, Medicines and Laboratories issues the national list of essential medicines; the 2022 edition lists cancer medicines, including trastuzumab, imatinib, rituximab and nivolumab, for use at national hospital level. The country enacted Law No. 035/PR/2019 of 5 August 2019 on universal health coverage, which provides for three schemes, with the decision to start with the one under which the state pays for the care of the poorest.
It places Chad among the countries still preparing to introduce the HPV vaccine in 2024 and names why that is hard.
The survey covers essential medicines in general, not cancer medicines, but it shows the supply system cancer care in Chad depends on: about half of listed medicines in stock in public facilities, and generics far cheaper than brands.
The authors argue that the high share of vaccine-preventable types is the rationale for introducing HPV vaccination for young adolescent girls in Chad, which WHO's data still record as not introduced.
Screening was accepted and possible in a regional town, but cytology alone could not be read for half the smears, and the authors suggest looking at the cervix after staining first, the approach of visual inspection.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, International Agency for Research on Cancer (IARC / WHO), Cervical cancer.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/